Original document(5 pages)  中文版
    This invention relates to a process for preparing drug containing arsenic for curing early period cervix cancer and skin cancer. Its main materials are white arsenic, alum, realgar and myrrh. Through the rechnologicals processes of pulverizing, weighting, high temp, calcining, cold storage and grinding, testing component, mixing and forming etc.. It is made into traditional Chinese tablet, stick and suppository type. The curing cancer drug produced with the process features of simple use, safety, well curing effect, high cure rate, also keeping woman's physiology and reproduction function, small side effect, no sequelae, etc..
Application Number
申请号
91111835 Application Date
申请日
1991.12.21
Title 名称 Process for preparing curing cancer drug
Publication Number
公开号
1061908 Publication Date
公开日
1992.06.17
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K35/02
Applicant(s) Name
申请人
Jiangxi Gynaecology an Obstetrics Hospital
Address 地址 330006
Inventor(s) Name 发明人 Li Hengyou, Liao Caisun
Attorney & Agent 代理人 CHEN LILING LI KE

  
Downgoing power control method in CDMA mobile communication system
Electromagnetic pumping unit
Dynamic channel allocating method
Intelligent fire extinguisher
Load control method of communication system and communicaton system and overload alarm device
Time synchronizing method and apparatus of communication system, device and system thereof
Method and access equipment for realizing soft-frequency duplexing and transmitting data
Sending method and system for synchronous signal
Synchronous pilot frequency sequence forming system and method in communication system
Apparatus, method and receiver for initial timing synchronization in communication system
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.